絞り込み

16733

広告

「"Folseraas T "[Author]」の検索結果

24件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities.

Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.

Neoplastic transformation of peribiliary stem cell niche in cholangiocarcinoma arisen in primary sclerosing cholangitis.

Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis.

Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.

Primary sclerosing cholangitis - a comprehensive review.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.

A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis.

Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.

Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells.

Genetics in PSC: What Do the "Risk Genes" Teach Us?

Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Genome-wide association analysis in sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.

  1. 1
  2. 2
Sort by
※並べ替えは表示に時間がかかります